94426 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
Sub-classes:ARYL HYDANTOIN COMPOUNDS AND METHODS OF USE
#2COMPOSITION FOR THE PREVENTION AND ELIMINATION OF ODORS
#3ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#4Method for producing methionine
#5Method for manufacturing a medium for purifying fluids containing toxic compounds
#6Androgen receptor modulators and methods for their use
#7IMIDAZOLIDINEDIONE DERIVATIVES
#8Hydantoins that modulate BACE-mediated app processing
#9N-halamine composition for the prevention and elimination of odors
#10HYDANTOINS THAT MODULATE BACE-MEDIATED APP PROCESSING
#11Hydantoin containing deoxyuridine triphosphatase inhibitors
#12Halogenated heterocyclic N-halamine coated garbage bags
#13Method of manufacturing particulate halogenated heterocyclic N-halamine compositions for the prevention and elimination of odors
#14Imidazolidinedione derivatives
#15Compounds, polymers and coating formulations that comprise at least one N-halamine precursor, a cationic center and a coating incorporation group
#16Halogenated heterocyclic N-halamine composition for the prevention and elimination of odors
#17Hydantoins that modulate BACE-mediated APP processing
#18Tricyclic sulfones as ROR gamma modulators
#19Imidazolidinedione derivatives
#20HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL
#21Imidazolidinedione derivatives
#22Method, device, and system for radio resource management measurement
#23Hydantoins that modulate BACE-mediated APP processing
#24Heterocyclic inhibitors of the sodium channel
#25Hydantoins that modulate bace-mediated app processing
#26Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof
#27Aggrecanase inhibitors
#28Method of production of a methionine salt
#29Imidazolidinedione derivatives
#30HYDANTOINS THAT MODULATE BACE-MEDIATED APP PROCESSING
#31Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
#32Process for producing optically active α-methylcysteine derivative
#33Method of production of a methionine salt
#34NOVEL N-PHENYLACETAMIDE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
#35Imidazolidinedione derivatives
#36Pyrimidone derivatives
#37Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof
#38N-halamine acrylamide monomers and copolymers thereof for biocidal coatings
#39Androgen receptor antagonists and uses thereof
#40Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
#41N-phenylacetamide derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them
#42(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
#43METHOD FOR PRODUCING METHIONINE
#44Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer
#45NEUROTROPHIN MIMETICS AND USES THEREOF
#46Compounds and methods for the treatment of pain and other diseases
#47Metalloproteinase Inhibitors
#48GAMMA SECRETASE MODULATORS
#49Metalloproteinase inhibitors
#50PROCESS FOR PRODUCING OPTICALLY ACTIVE ALPHA-METHYLCYSTEINE DERIVATIVE
#515 substituted hydantoins
#52Substituted carbinol compound
#53Hydantoins Having RNase Modulatory Activity
#54Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#55(2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors
#56Derivatives of seleno-amino acids
#57INHIBITORS OF VIRAL REPLICATION
#58Process to prepare sulfonyl chloride derivatives
#59Sodium channel blockers
#60DERIVATIVES OF SELENO-AMINO ACIDS
#61Metalloproteinase inhibitors
#62Metalloproteinase inhibitors
#63PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE HYDROXYMETHYL-SUBSTITUTED PHENYLALANINE
#64Hydantoin derivatives useful as antibacterial agents
#65Metalloproteinase inhibitors
#66CYCLOALKYLFUSED INDOLE, BENZOTHIOPHENE, BENZOFURAN AND INDENE DERIVATIVES
#67Therapeutic substituted hydantoins and related compounds
#68Imidazolidine derivatives
#69Substituted hydantoins
#70Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#71Peptide deformylase inhibitors
#72CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION
#73Aralkyl ester soft drugs
#74Derivatives of seleno-amino acids
#75Optically active 3,3'-dithiobis(2-amino-2methylpropionic acid) derivative and process for producing optically active 2-amino-3-mercapto-2-methylpropionic acid derivative
#76Method and compositions for temporarily incapacitating subjects
#77Bicyclic anilide spirohydantoin CGRP receptor antagonists
#78Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives
#79Aminobenzophenone compounds
#80Imidazolidinedione analogs useful as anticoagulants and antithrombotics
#81Oral general anesthetics and metabolitically resistant anticonvulsants
#82Process for producing optically active alpha-methylcysteine derivative
#83Hydantoin derivatives and deren verwendung als tace inhibitoren
#84Process for producing l-alpha-methylcysteine derivative
#85I-sulphonlyl piperidine derivatives
#86Method for producing lysine derivative
#87Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#88Sulphonamide derivatives and their use as tace inhibitors
#89Cycloalkyl inhibitors of potassium channel function
#90Sodium channel blockers
#91Hydantoins having RNase modulatory activity
#92Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
#93Amidino compounds useful as nitric oxide synthase inhibitors
#94Monocyclic -Aryl hydantoin modulators of androgen receptor function
#95Peptide deformylase inhibitors
#96Peroxisome proliferator activated receptor agonists
#974-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]butanoic acid as an antimicrobial compound
#98Ethyl 3-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]propanoate as an antimicrobial compound
#993-[4,4-bis(4-nitrophenyl)-2,5-dioxoimidazolidin-1-yl]propanoic acid as an antimicrobial compound
#1006-[4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]hexanoic acid as an antimicrobial compound